AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7536691 — intervention group
Group type: COMPARATOR
Intervention: Bypassed groups
Number of subjects: 233
Study 2655500 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle bevel oriented perpendicular to longitudinal dural fibers
Number of subjects: 41
Study 2655500 — intervention group
Group type: COMPARATOR
Intervention: Needle bevel oriented parallel to longitudinal dural fibers
Number of subjects: 41
Study 2655500 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic blood patch administered to perpendicular group
Number of subjects: 41
Study 2655500 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic blood patch administered to parallel group
Number of subjects: 41
Study 355181 — intervention group
Group type: EXPERIMENTAL
Intervention: Butaclamol
Number of subjects: 24
Study 355181 — intervention group
Group type: COMPARATOR
Intervention: Fluphenazine
Number of subjects: 24
Study 31201479 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronabinol (2.5 mg)
Number of subjects: 10
Study 31201479 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronabinol (5 mg)
Number of subjects: 10
Study 31201479 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone (5 mg)
Number of subjects: 10
Study 31201479 — intervention group
Group type: COMPARATOR
Intervention: Oxycodone (0, 5, 10 mg)
Number of subjects: 10
Study 31201479 — intervention group
Group type: COMPARATOR
Intervention: Dronabinol (0, 2.5, 5 mg)
Number of subjects: 10
Study 27959717 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor (90 mg twice daily)
Number of subjects: 13885
Study 27959717 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (75 mg once daily)
Number of subjects: 13885
Study 27959717 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 13885
Study 27959717 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 13885
Study 25234100 — intervention group
Group type: EXPERIMENTAL
Intervention: LED phototherapy
Number of subjects: 150
Study 25234100 — intervention group
Group type: COMPARATOR
Intervention: Daylight phototherapy
Number of subjects: 150
Study 24652498 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine-azithromycin
Number of subjects: 0
Study 24652498 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine
Number of subjects: 0
Study 23040652 — intervention group
Group type: EXPERIMENTAL
Intervention: G1: 20mL L+10mL M
Number of subjects: 120
Study 23040652 — intervention group
Group type: EXPERIMENTAL
Intervention: G2: 10mL L+20mL M
Number of subjects: 120
Study 23040652 — intervention group
Group type: EXPERIMENTAL
Intervention: G3: 15mL L+15mL M
Number of subjects: 120
Study 23040652 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study 19888533 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone treatment (testosterone undecanoate 1,000 mg, intramuscular injections, 5 injections over 40 weeks)
Number of subjects: 26
Study 19888533 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 17301632 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month training
Number of subjects: 50
Study 17301632 — intervention group
Group type: COMPARATOR
Intervention: Not trained (control group)
Number of subjects: 50
Study 15333077 — intervention group
Group type: EXPERIMENTAL
Intervention: Brugada syndrome patients with VA induced by PES
Number of subjects: 15
Study 15333077 — intervention group
Group type: EXPERIMENTAL
Intervention: Brugada syndrome patients without VA
Number of subjects: 15
Study 15333077 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 15
Study 11121982 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave lithotripsy (ESWL)
Number of subjects: 228
Study 11121982 — intervention group
Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 228
Study 9872339 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous rizatriptan (0.5-5 mg)
Number of subjects: 0
Study 7523132 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral microwave thermotherapy (TUMT) for 1 hour
Number of subjects: 40
Study 7523132 — intervention group
Group type: COMPARATOR
Intervention: Transurethral catheter therapy for 1 hour (Control)
Number of subjects: 40
Study 7523132 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral microwave thermotherapy (TUMT)
Number of subjects: 40
Study 7523132 — intervention group
Group type: COMPARATOR
Intervention: Transurethral catheter therapy (Control)
Number of subjects: 40
Study 2802836 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose recombinant human growth hormone (GH)
Number of subjects: 18
Study 2802836 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 30515674 — intervention group
Group type: EXPERIMENTAL
Intervention: palbociclib (125 mg/day [3 weeks on/1 week off]) plus letrozole (2.5 mg daily)
Number of subjects: 46
Study 30515674 — intervention group
Group type: COMPARATOR
Intervention: placebo plus letrozole
Number of subjects: 46
Study 28455600 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib 120 mg oral preoperatively
Number of subjects: 60
Study 28455600 — intervention group
Group type: COMPARATOR
Intervention: Placebo oral preoperatively
Number of subjects: 60
Study 25840467 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibition training
Number of subjects: 0
Study 25840467 — intervention group
Group type: COMPARATOR
Intervention: Attention training
Number of subjects: 0
Study 23046593 — intervention group
Group type: EXPERIMENTAL
Intervention: Right transradial approach (RTA)
Number of subjects: 40
Study 23046593 — intervention group
Group type: COMPARATOR
Intervention: Left transradial approach (LTA)
Number of subjects: 40
Study 23046593 — intervention group
Group type: EXPERIMENTAL
Intervention: Procedures needing >2 catheters
Number of subjects: 40
Study 23046593 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing number of catheters
Number of subjects: 40
Study 21208583 — intervention group
Group type: EXPERIMENTAL
Intervention: SSRI treatment
Number of subjects: 334
Study 21208583 — intervention group
Group type: COMPARATOR
Intervention: Venlafaxine
Number of subjects: 334
Study 21208583 — intervention group
Group type: EXPERIMENTAL
Intervention: Remission
Number of subjects: 334
Study 21208583 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonremitters
Number of subjects: 334
Study 18359622 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% dehydroepiandrosterone (DHEA) applied twice daily for 12 months
Number of subjects: 150
Study 17238472 — intervention group
Group type: EXPERIMENTAL
Intervention: computer-based patient 'roadmap'
Number of subjects: 20800000
Study 12730532 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-monthly i.v. ibandronate (2 mg) bolus injections
Number of subjects: 104
Study 12730532 — intervention group
Group type: COMPARATOR
Intervention: Oral daily alfacalcidol (1 micro g)
Number of subjects: 104
Study 11361273 — intervention group
Group type: EXPERIMENTAL
Intervention: Ayurvedic therapeutics (AT)
Number of subjects: 0
Study 9299911 — intervention group
Group type: EXPERIMENTAL
Intervention: Left hemisphere group (attended left ear)
Number of subjects: 100
Study 9299911 — intervention group
Group type: COMPARATOR
Intervention: Right hemisphere group (attended right ear)
Number of subjects: 100
Study 8291115 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabbit antithymocyte serum (RATS)
Number of subjects: 166
Study 8291115 — intervention group
Group type: COMPARATOR
Intervention: OKT3
Number of subjects: 166
Study 2833090 — intervention group
Group type: COMPARATOR
Intervention: Lisinopril alone (group A)
Number of subjects: 26
Study 2833090 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril plus hydrochlorothiazide (group B)
Number of subjects: 26
Study 31694364 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic walking and cognitive training (group NW+C)
Number of subjects: 61
Study 31694364 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic walking classes (group NW)
Number of subjects: 61
Study 31694364 — intervention group
Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 61
Study 28400163 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress condition prior to extinction learning
Number of subjects: 49
Study 28400163 — intervention group
Group type: COMPARATOR
Intervention: Control condition prior to extinction learning
Number of subjects: 49
Study 26335224 — intervention group
Group type: EXPERIMENTAL
Intervention: 37.5 mg daily sunitinib therapy
Number of subjects: 20
Study 26335224 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline FDG-PET
Number of subjects: 20
Study 26335224 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline FLT-PET
Number of subjects: 20
Study 22903515 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (400 μg every 6 h)
Number of subjects: 134
Study 22903515 — intervention group
Group type: COMPARATOR
Intervention: Vaginal misoprostol (400 μg every 6 h)
Number of subjects: 134
Study 21505939 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined whole body vibration and balance training
Number of subjects: 66
Study 21505939 — intervention group
Group type: COMPARATOR
Intervention: Comprehensive inpatient geriatric rehabilitation program
Number of subjects: 66
Study 19175963 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at sites reported to cause onset of labour
Number of subjects: 16
Study 19175963 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture at nearby sites
Number of subjects: 16
Study 16497616 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodenal lipids during jejunal gas challenge
Number of subjects: 32
Study 16497616 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodenal amino acids during jejunal gas challenge
Number of subjects: 32
Study 16497616 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodenal lipids during ileal gas challenge
Number of subjects: 32
Study 16497616 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodenal amino acids during ileal gas challenge
Number of subjects: 32
Study 16497616 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodenal glucose during jejunal gas challenge
Number of subjects: 32
Study 16497616 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodenal glucose during ileal gas challenge
Number of subjects: 32
Study 12929021 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS‐FNA with histological and cytological evaluation
Number of subjects: 41
Study 12929021 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS‐FNA with cytological examination
Number of subjects: 41
Study 12929021 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS‐FNA with histological assessment
Number of subjects: 41
Study 12929021 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS‐FNA with combined modalities
Number of subjects: 41
Study 12929021 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS‐FNA
Number of subjects: 41
Study 10689266 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg/day
Number of subjects: 437
Study 10689266 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 437
Study 9496289 — intervention group
Group type: EXPERIMENTAL
Intervention: Near patient testing (NPT) of whole blood sample
Number of subjects: 306
Study 9496289 — intervention group
Group type: COMPARATOR
Intervention: Routine method (courier transport of citrated sample to the laboratory for analysis)
Number of subjects: 306
Study 9496289 — intervention group
Group type: COMPARATOR
Intervention: Control method (plasma separated and frozen in liquid nitrogen, transported to the laboratory)
Number of subjects: 306
Study 8449053 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing cold air (-13 degrees C)
Number of subjects: 19
Study 8449053 — intervention group
Group type: COMPARATOR
Intervention: Breathing room air
Number of subjects: 19
Study 3307440 — intervention group
Group type: EXPERIMENTAL
Intervention: +1.00 D add bifocals
Number of subjects: 207
Study 3307440 — intervention group
Group type: EXPERIMENTAL
Intervention: +2.00 D add bifocals
Number of subjects: 207
Study 3307440 — intervention group
Group type: EXPERIMENTAL
Intervention: Single vision lenses
Number of subjects: 207
Study 30458838 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI intervention with bihemispheric beta activity and adaptive support vector machine
Number of subjects: 37
Study 30458838 — intervention group
Group type: EXPERIMENTAL
Intervention: Decoding based on brain activity
Number of subjects: 37
Study 27635998 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized cognitive exercise training (CT)
Number of subjects: 213
Study 27635998 — intervention group
Group type: COMPARATOR
Intervention: Computerized relaxation (control)
Number of subjects: 213
Study 25542295 — intervention group
Group type: EXPERIMENTAL
Intervention: Glatiramer acetate 40 mg/mL three‐times weekly (GA40)
Number of subjects: 1292
Study 25542295 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1292
Study 24005315 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 5000 IU/week
Number of subjects: 39
Study 24005315 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 7000 IU/week
Number of subjects: 39
Study 24005315 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 39
Study 24005315 — intervention group
Group type: EXPERIMENTAL
Intervention: GHD patients with 25(OH)D ≥15 ng/ml
Number of subjects: 39
Study 24005315 — intervention group
Group type: EXPERIMENTAL
Intervention: GHD patients with 25(OH)D <15 ng/ml
Number of subjects: 39
Study 20961422 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.83 mg/mL liquid formulation
Number of subjects: 30
Study 20961422 — intervention group
Group type: EXPERIMENTAL
Intervention: 8.0 mg/mL liquid formulation
Number of subjects: 30
Study 20961422 — intervention group
Group type: COMPARATOR
Intervention: Freeze-dried (FD) formulation
Number of subjects: 30
Study 17890048 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye movement
Number of subjects: 48
Study 17890048 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye movement with distancing instruction
Number of subjects: 48
Study 17890048 — intervention group
Group type: COMPARATOR
Intervention: Therapist instructions (reliving or distancing)
Number of subjects: 48
Study 16904048 — intervention group
Group type: EXPERIMENTAL
Intervention: Management with PAC
Number of subjects: 1014
Study 16904048 — intervention group
Group type: COMPARATOR
Intervention: Management without PAC (Control)
Number of subjects: 1014
Study 16904048 — intervention group
Group type: EXPERIMENTAL
Intervention: Economic evaluation of PAC
Number of subjects: 1014
Study 12750540 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytics
Number of subjects: 23
Study 12750540 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 23
Study 10994151 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation (amlodipine tablet broken into two halves and encapsulated)
Number of subjects: 18
Study 10994151 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation (amlodipine tablet broken into two halves and ingested as such)
Number of subjects: 18
Study 10994151 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation
Number of subjects: 18
Study 10994151 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation
Number of subjects: 18
Study 8681596 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (4 micrograms/kg iv)
Number of subjects: 48
Study 8681596 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 2001018 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane 3% (approximately 0.5 MAC)
Number of subjects: 38
Study 2001018 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane 0.6% (approximately 0.5 MAC)
Number of subjects: 38
Study 6135507 — intervention group
Group type: EXPERIMENTAL
Intervention: Lormetazepam (1 mg)
Number of subjects: 50
Study 6135507 — intervention group
Group type: COMPARATOR
Intervention: Amobarbital sodium (100 mg)
Number of subjects: 50
Study 30998125 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 54
Study 30998125 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprint Interval Training (SIT)
Number of subjects: 54
Study 30998125 — intervention group
Group type: COMPARATOR
Intervention: Control Group (Normoglycemic)
Number of subjects: 54
Study 30998125 — intervention group
Group type: EXPERIMENTAL
Intervention: Both MICT and SIT
Number of subjects: 54
Study 29327213 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive curcumin (500 to 1500 mg/day)
Number of subjects: 65
Study 29327213 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 29327213 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive curcumin
Number of subjects: 65
Study 26701171 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness‐Oriented Recovery Enhancement (MORE)
Number of subjects: 180
Study 26701171 — intervention group
Group type: COMPARATOR
Intervention: Cognitive‐Behavioral Therapy (CBT)
Number of subjects: 180
Study 26701171 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-Usual (TAU)
Number of subjects: 180
Study 24152823 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher systolic blood pressure level (SBPL)
Number of subjects: 1087
Study 24152823 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower carotid distensibility
Number of subjects: 1087
Study 24152823 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher carotid-femoral pulse wave velocity
Number of subjects: 1087
Study 22374612 — intervention group
Group type: EXPERIMENTAL
Intervention: Perfusion group (DXM 2.5 mg/0.5 ml perfused transtympanically for 1 h twice a day for 7 days, total 35.0 mg)
Number of subjects: 55
Study 22374612 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection group (DXM 2.5 mg injected by tympanic membrane puncture at intervals of 2 days for a total of 4 occasions, total 10.0 mg)
Number of subjects: 55
Study 22374612 — intervention group
Group type: EXPERIMENTAL
Intervention: Drip group (DXM 2.5 mg/0.5 ml dripped via a ventilation tube once on the first day and twice a day for the remaining 6 days, total 32.5 mg)
Number of subjects: 55
Study 22374612 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 55
Study 20595201 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritive solutions (sucrose and NaCl)
Number of subjects: 16
Study 20595201 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmful solutions (quinine and capsaicin)
Number of subjects: 16
Study 20595201 — intervention group
Group type: COMPARATOR
Intervention: Tasteless control solution
Number of subjects: 16
Study 18341178 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment of 2 NRTI + 1 NNRTI (51%), 3 NRTI (45%), 2 NRTI + 1 PI (4%)
Number of subjects: 112
Study 16619818 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloramphenicol
Number of subjects: 166
Study 16619818 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamycin
Number of subjects: 166
Study 16619818 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 166
Study 16619818 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin
Number of subjects: 166
Study 16619818 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 166
Study 12067838 — intervention group
Group type: EXPERIMENTAL
Intervention: R-beta-hydroxybutyrate infusion
Number of subjects: 12
Study 10215759 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-electrostatic Babyhaler (coated with benzalkonium chloride)
Number of subjects: 5
Study 10215759 — intervention group
Group type: EXPERIMENTAL
Intervention: New Babyhaler (rinsed in water)
Number of subjects: 5
Study 10215759 — intervention group
Group type: EXPERIMENTAL
Intervention: New AeroChamber (rinsed in water)
Number of subjects: 5
Study 8550258 — intervention group
Group type: EXPERIMENTAL
Intervention: Effleurage massage of the quadriceps muscles for four days
Number of subjects: 0
Study 8550258 — intervention group
Group type: COMPARATOR
Intervention: Control leg (no massage)
Number of subjects: 0
Study 8550258 — intervention group
Group type: EXPERIMENTAL
Intervention: Effleurage massage of the quadriceps muscles
Number of subjects: 0
Study 8550258 — intervention group
Group type: EXPERIMENTAL
Intervention: Light quadriceps muscle contractions
Number of subjects: 0
Study 2225290 — intervention group
Group type: EXPERIMENTAL
Intervention: Enflurane-N2O anaesthesia
Number of subjects: 30
Study 2225290 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane-N2O anaesthesia
Number of subjects: 30
Study 760753 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol (1000 mg)
Number of subjects: 12
Study 760753 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral paracetamol (1000 mg)
Number of subjects: 12
Study 760753 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary excretion of free and conjugated paracetamol
Number of subjects: 12
Study 30807834 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy (aPDT) with low intensity laser (InGaAlP) and 0.005% methylene blue photosensitizer
Number of subjects: 20
Study 30807834 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective caries removal
Number of subjects: 20
Study 30807834 — intervention group
Group type: COMPARATOR
Intervention: Control group (no aPDT)
Number of subjects: 20
Study 28133925 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept (10 mg/kg intravenously on days 1, 15, 29, and week 8)
Number of subjects: 49
Study 28133925 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 28133925 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 49
Study 25265472 — intervention group
Group type: EXPERIMENTAL
Intervention: peginterferon beta‐1a 125 μg every 2 weeks
Number of subjects: 1512
Study 25265472 — intervention group
Group type: EXPERIMENTAL
Intervention: peginterferon beta‐1a 125 μg every 4 weeks
Number of subjects: 1512
Study 25265472 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1512
Study 23425501 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surgery (<48 hours)
Number of subjects: 76
Study 23425501 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 76
Study 21883125 — intervention group
Group type: EXPERIMENTAL
Intervention: Bristol group (fentanyl 1-2 μg.kg(‐1) and diclofenac 1-2 mg.kg(‐1))
Number of subjects: 65